Open access peer-reviewed chapter

Antitubercular Drugs Development: Recent Advances in Selected Therapeutic Targets and Rational Drug Design

By Virgilio Bocanegra-García, Abraham García, Jose Prisco Palma-Nicolás, Isidro Palos and Gildardo Rivera

Submitted: February 22nd 2011Reviewed: August 15th 2011Published: December 7th 2011

DOI: 10.5772/27735

Downloaded: 7996

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Virgilio Bocanegra-García, Abraham García, Jose Prisco Palma-Nicolás, Isidro Palos and Gildardo Rivera (December 7th 2011). Antitubercular Drugs Development: Recent Advances in Selected Therapeutic Targets and Rational Drug Design, Drug Development - A Case Study Based Insight into Modern Strategies, Chris Rundfeldt, IntechOpen, DOI: 10.5772/27735. Available from:

chapter statistics

7996total chapter downloads

1Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Insight into the Key Structural Features of Potent Enoyl Acyl Carrier Protein Reductase Inhibitors Based on Computer Aided Molecular Design

By Auradee Punkvang, Pharit Kamsri, Kodchakon Kun-asa, Patchreenart Saparpakorn, Supa Hannongbua, Peter Wolschann and Pornpan Pungpo

Related Book

First chapter

Autobioluminescent Cellular Models for Enhanced Drug Discovery

By Tingting Xu, Michael Conway, Ashley Frank, Amelia Brumbaugh, Steven Ripp and Dan Close

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us